Cengiz Ceylan

Cengiz Ceylan

Auto-generated profile, based on publicly available information

Cengiz Ceylan

Hematology Department, İzmir City Hospital, Bayrakli/İzmir, Turkey

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Southern Medical Journal
Verified
Journal Article
Closed access
ECEmel Ceylan
Emel Ceylan
AÇAbdurrahman Çömlekçi
Abdurrahman Çömlekçi
AAAtila Akkoçlu
Atila Akkoçlu
CCCengiz Ceylan
Cengiz Ceylan
OIOya İtil
Oya İtil
SYSena Yeşil
Sena Yeşil
Objectives:To determine the predominant pulmonary function abnormality in overweight and moderately obese subjects and to evaluate the correlation between the severity of lung function impairment and the degree of obesity.Methods:Fifty-three volunteers underwent physical examination, skin fold measurements, and standardized pulmonary function tests. Thirty-one women and 22 men with a mean age of...

10 January 2007 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
CCC. Ceylan
C. Ceylan
MMM. Miskioğlu
M. Miskioğlu
HÇH. Çolak
H. Çolak
BKB. Kiliççioğlu
B. Kiliççioğlu
EÖE. Özdemir
E. Özdemir

1 May 2005 in Metabolism
Verified
Journal Article
Closed access
ASAli Saklamaz
Ali Saklamaz
ACAbdurrahman Comlekci
Abdurrahman Comlekci
AAAysegül Temiz Artmann
Aysegül Temiz Artmann
SCSezer Caliskan
Sezer Caliskan
CCCengiz Ceylan
Cengiz Ceylan
SYSena Yesil
Sena Yesil

1 March 2005 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
YBYesim Bulbul Baytur
Yesim Bulbul Baytur
MCMine Cabuk
Mine Cabuk
FKFaik M. Koyuncu
Faik M. Koyuncu
SLSelman Lacin
Selman Lacin
CCCengiz Ceylan
Cengiz Ceylan
AKAli Riza Kandiloglu
Ali Riza Kandiloglu

1 April 2004 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
MÇMine Çabuk
Mine Çabuk
IIIşil Inanir
Işil Inanir
PTPeyker Türkdoğan
Peyker Türkdoğan
CCCengiz Ceylan
Cengiz Ceylan
MDMustafa Değirmenci
Mustafa Değirmenci
EÖErtan Özdemir
Ertan Özdemir
Lymphocytic cutaneous vasculitis associated with a haematological malignancy has rarely been reported. Here, we describe a 61 year-old woman with chronic lymphocytic leukemia (CLL) who presented with cutaneous lesions on both hands. These lesions improved after all combination chemotherapy courses and recurred before each course. Repetitive skin biopsies revealed lymphocytic vasculitis. After 7 courses of chemotherapy, she had a complete remission. Skin lesions disappeared and did not recur. The cyclic pattern of lymphocytic vasculitis and its relation with CLL disease activity are interesting clinical features in this case.

1 October 2018 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
AŞAslı Gamze Şener
Aslı Gamze Şener
NANeriman Aydın
Neriman Aydın
CCCengiz Ceylan
Cengiz Ceylan
SKSevin Kırdar
Sevin Kırdar
Antinuclear antibodies (ANA) facilitate the diagnosis and evaluation of patients in many systemic autoimmune conditions. Besides, ANA may also be detected in chronic infectious diseases. Although a number of investigations associated with autoantibody positivity in patients with chronic hepatitis C were reported, autoantibody positivity in patients with chronic hepatitis B remain rarely addressed in the literature. The aim of this study was to evaluate the antinuclear antibody (ANA), antimitocondrial antibody (AMA), anti-smooth muscle antibodies (ASMA) and anti-liver-kidney microsomal antigen (LKM) antibodies in chronic hepatitis B patients. Serum samples were obtained from adult patients with chronic hepatitis B diagnosis according to "European Association for the Study of the Liver (EASL)" criteria. Samples were taken from 47 patients (22 female, 25 male) with treatment-naive, histologically-proven chronic hepatitis B. Cases co-infected with HCV and/or HIV or that also had systemic autoimmune diseases were excluded. As a control group, 30 healthy blood donors were included in the study. Autoantibodies, including ANA, AMA, ASMA and LKM were detected with indirect immunofluorescence (IIF) method (Euroimmune, Lubeck, Germany) and evaluated by fluorescence microscope (Eurostar III plus, Germany). Positive results were graded into 4 levels ( "+", "++","+++" and "++++") from weak to strong Positive samples were studied with a immunoblotting method (ANA Profile 3, Euroimmun, AG) for the detection of extractable nuclear antigen (ENA). The positive results were detected in 8 (17%) of the HBV patients while all the samples were negative in the control group. The difference between the groups was significant (p< 0.05). Among the 47 serum samples tested, none of the patients were positive for AMA, ASMA, LKM. ANA was present in eight of the serum samples in which six were female and two were male patients. Among the IIF patterns of ANA positivity, one mixed pattern (homogeneous and nucleolar) and one cytoplasmic anti-golgi antibody pattern were detected. Positivity grade was ''++''. Other positive patterns were nucleolar (two patients), granular (two patients), ribozomal (one patient) and homogeneous (one patient) and positivity grade was ''+''. ENA was detected in three samples. Two of them was granular pattern positive samples. SS-A was borderline (±) in one and SS-B was borderline (±) in one of the samples. In the mixed pattern positive sample, histon was detected as ''+''. Autoantibody positivity between the patient and control groups were statistically significant (p< 0.05). The difference between autoantibody positivity and gender/age was not statistically significant. In conclusion, autoimmune manifestations may be detected in patients with chronic hepatitis B. Low level titer of antibodies such as ANA, AMA, ASMA or LKM may be present in such patients. An increased frequency of these autoantibodies may be associated with non-autoimmune conditions such as chronic viral infection even in treatment-naive patients.